The Cancer Therapies market is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX%. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy.
Rise in cancer incidences and access to modern therapeutics, population of aged people, efficiency and high price magnetize manufacturers and innovations, improvements and approvals promote growth are some of the major drivers of cancer therapy market.
High price of therapies, change in reimbursement policies and challenges encountered in clinical trials are retraining cancer therapy market.
Market is segmented based on cancer types (blood cancer, bone cancer, brain cancer, breast cancer, digestive/ gastrointestinal cancer, endocrine cancer, eye cancer, genitourinary cancer, gynaecologic cancer, head & neck cancers, respiratory/lung cancer and skin cancer), treatment types (surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormonal therapy, hyperthermia, stem cell transplant and other therapies), based on therapies Targeted cancer therapies ( Hormone therapy, Signal transduction inhibitors, gene expression modulators, Apoptosis inducers etc.), Hormone therapies( Forms of hormone therapy) , immunotherapy( Monoclonal antibodies, Cancer vaccines, Non-specific immunotherapies) ,Chemotherapy. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. The segment on North American region includes Canada, the United States and Mexico. The European region includes the United Kingdom, Germany, France, Italy, Spain, and rest of Europe. The Asia-Pacific region includes Australia, New Zealand, China, India, Japan, South Korea, and rest of Asia-Pacific. The Middle East and Africa (MEA) region includes GCC, South Africa and rest of MEA. South America region includes Brazil, Argentina and rest of South America.
Some of the key players in this market include –
Major companies in the market include Dendreon, Galena Biopharma, Newlink genetics, Astrazeneca Plc, Chugai Pharmaceutical Co., Ltd., and Genentech Inc.
Market analysis for the market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the Cancer Therapies Market. Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.